
Nonspecific, nondolent symptoms make this disease difficult to diagnose.

Nonspecific, nondolent symptoms make this disease difficult to diagnose.

Investigators apply guidelines into practical management strategies.

The challenging search for a metric that effectively evaluates an ASP’s direct impact on appropriate antimicrobial use and improved patient outcomes.

More treatment options and modalities are now available for patients.

EVD outbreaks this year serve as a reminder of the virus’ severity and the importance of having a containment strategy in place.

Examining pharmacological management in COVID-19 patients with ARDS requiring antifungal therapy during extracorporeal life support.

The recombinant human IgG1κ monoclonal antibody binds and neutralizes the virus.


